US-based pharma giant Eli Lilly’s blockbuster weight-loss drug, Mounjaro, is set to expand its reach across India through a ...

Cipla will market Eli Lilly’s diabetes and weight-loss drug Mounjaro as Yurpeak in India, enhancing accessibility and ...

Hims & Hers is emerging as a disruptive force in the obesity treatment market, challenging established GLP-1 drug makers. Read why HIMS stock is a Hold.

What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to get a fifth dose out of Mounjaro.

GLP-1 medications like Ozempic and Wegovy are reducing users' appetites, leading to changes in dining habits. Some restaurants are beginning to adapt by offering smaller portions and specialized menus ...

Costco is selling the popular weight-loss drugs for $499 a month, a steep discount, as rising obesity boosts demand for the drugs and their cheaper copycats. Popular weight-loss drugs Ozempic and ...

Liz just wanted to lose the baby weight. Like so many other moms, the 33-year-old was struggling to fit into her clothes postpartum. She considered compounded versions of weight-loss drugs like ...

Forbes contributors publish independent expert analyses and insights. Pam Danziger reports on retail, focused on the luxury consumer market. GLP-1 drugs like Ozempic are rapidly shifting American body ...